CITIC Overseas Direct: Net profit in the first quarter was 83.5422 million yuan, a year-on-year increase of 21.69%

stock analyst • • US Stocks Focus

CITIC HaiZhi (000099) disclosed its first quarter report on the evening of April 25. The company achieved operating income of 457 million yuan in the first quarter of 2024, a year-on-year increase of 12.96%; net profit was 83.5422 million yuan, a year-on-year increase of 21.69%.

CITIC HaiZhi (000099) disclosed its first quarter report on the evening of April 25. The company achieved operating income of 457 million yuan in the first quarter of 2024, a year-on-year increase of 12.96%; net profit was 83.5422 million yuan, a year-on-year increase of 21.69%.

Like (0)
stock analyststock analyst
Previous April 25, 2024 7:59 pm
Next April 25, 2024 7:59 pm

Related posts

  • Musk talks about how to solve the global water crisis

    This week, Tesla and SpaceX CEO Elon Musk spoke at the World Water Forum in Bali on Monday and shared some insights into solving the water crisis.

    US Stocks Focus May 21, 2024

  • Holley Technology: Net profit in the first quarter was 19.9762 million yuan, a year-on-year increase of 247.51%

    Securities Times e Company News, Holley Technology (301011) disclosed its first quarter report on the evening of April 25. The company achieved operating income of 215 million yuan in the first quarter of 2024, a year-on-year increase of 37.6%, which was mainly derived from the company’s game entertainment equipment and animation IP. Product sales revenue increased compared with the same period last year; net profit was 19.9762 million yuan, a year-on-year increase of 247.51%.

    US Stocks Focus April 25, 2024

  • The vaccine market is turbulent, and Zhifei Biotech’s “big brother” status is difficult to maintain

    For stock trading, please read Jin Qilin analyst research reports. They are authoritative, professional, timely and comprehensive, helping you to tap potential theme opportunities! Source: Financial Investment News Financial Investment News reporter Chen Yuhe After Zhifei Biotechnology (300122), the “vaccine brother”, released its 2023 annual report, its stock price continued to fall. Some market participants attributed its falling stock price to its high reliance on foreign supplies. Business is linked to the gradually revealed decline in performance. In recent years, the vaccine market has been changing. On the one hand, the once \”hot-selling\” nine-price HPV vaccine is no longer hard to find. On the other hand, various good news about the domestically produced nine-price HPV vaccine continue to spread, attracting a lot of attention. Institutions pay great attention to its listing process. Zhifei Bio\’s growth capability indicators Zhi Fei Bio\’s stock price continues to fall. The annual report shows that in 2023, Zhi Fei Bio\’s operating income was 52.918 billion yuan, a year-on-year increase of 38.3%; it achieved net profit attributable to the parent company of 8.07 billion yuan, a…

    US Stocks Focus April 25, 2024

  • Quant MF appoints Kataria as CFO

    Quant Mutual Fund, under SEBI lens in a front-running case, has appointed Shashi Kataria as Chief Financial Officer.

    US Stocks Focus July 28, 2024

  • Buzzing stocks.Stocks that will see action today: May 2, 2024

    Godrej family announced a family settlement under which Adi Godrej and Nadir Godrej will control the listed companies in the group while Jamshyd Godrej and Nyrika Holkar will control Godrej Enterprises comprising Godrej & Boyce and its affiliates. The listed entities under Godrej Industries Group (GIG) are Godrej Industries, Godrej Consumer Products, Godrej Properties, Godrej Agrovet and Astec Lifesciences.

    US Stocks Focus May 3, 2024

  • U.S. cryptocurrency exchange Coinbase is investigating a system-wide service outage

    Coinbase Global Inc., the largest cryptocurrency exchange in the United States. Experiencing a system-wide service outage

    US Stocks Focus May 14, 2024